|
| The authors developed two monkeypox virus quadrivalent mRNA vaccines, named mRNA-A-LNP and mRNA-B-LNP, based on two intracellular mature virus-specific proteins, A29L and M1R, and two extracellular enveloped virus-specific proteins, A35R and B6R. [Signal Transduction and Targeted Therapy] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Researchers showed that single severe acute respiratory syndrome coronavirus 2-specific memory B cell clones showed plasticity upon antigen rechallenge in previously exposed individuals. [Nature Immunology] |
|
|
|
| Scientists investigated the mechanism by which the SARS-CoV-2 papain-like protease (PLpro) antagonizes cellular antiviral response and revealed how SARS-CoV-2 PLpro inhibited type I interferon signaling through stimulator of interferon genes (STING) deubiquitination. [Science Signaling] |
|
|
|
| Investigators evaluated and compared the immune responses induced by six different spike protein vaccines targeting the ancestral or various Omicron strains of SARS-CoV-2 in mice. [MedComm] |
| MORE IMMUNOLOGY OF INFECTIOUS DISEASE |
|
|
|
| Scientists performed single-cell RNA sequencing using testes from Zika virus (ZIKV)-infected mice to address the mechanisms underlying ZIKV’s influence on male reproductive health during an infection. [Nature Communications] |
|
|
|
| Investigators observed that Toll-like receptor 3 (TLR3), stimulator of interferon genes (STING), TLR8, and Dectin-1 ligands inhibited arboviruses, Chikungunya virus, West Nile virus, and Zika virus to varying degrees. [Cell Reports Medicine] |
|
|
|
| Researchers showed that B cell Toll-like receptor 4 (TLR4)–B cell receptor (BCR) coengagement by 4-hydroxy-3-nitrophenyl acetyl (NP)–lipopolysaccharide or TLR5-BCR coengagement by Salmonella flagellin induced mature antibody responses to NP and flagellin in Tcrβ−/−Tcrδ−/− and NSG/B mice. [Science Advances] |
|
|
|
| Investigators designed a new HIV-1 envelope glycoprotein nanoparticle (Env/NP) vaccine using amphiphilic polymers. The Env/NP vaccine induced more potent and broader neutralizing activities against multiple HIV-1 subtypes. [Nano Letters] |
|
|
|
| Scientists found that a wild-type alphavirus, Semliki Forest virus, triggered the Dicer-dependent production of virus-derived small interfering RNAs in both mammalian somatic cells and adult mice. [Cell Reports] |
|
|
|
|
| The authors focus on the function of CXCR5+CD8+ T cells in hepatitis B virus (HBV) infection and discuss the function of these CD8+ T cells and the potential of associated co-stimulators or cytokines in HBV therapeutic strategies. [Journal Of Viral Hepatitis] |
|
|
|
|
| The US FDA approved Arexvy, the first RSV vaccine approved for use in the United States. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older. [FDA] |
|
|
|
| The Minister of Innovation, Science and Industry, announced $1.4 billion in support of 11 large-scale research initiatives through the Canada First Research Excellence Fund (CFREF). McGill is the recipient of a landmark $165 million CFREF grant. [McGill University] |
|
|
|
|
| June 7 – 9, 2023 Paris, France |
|
|
|
|
|
| Nagasaki University – Nagasaki, Japan |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| The University of Southern California – Los Angeles, California, United States |
|
|
|
| National Institutes of Health – Bethesda, Maryland, United States |
|
|
|
|